SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Regina Sala, Benjamin I. Goldstein, Shuai Wang, Carlos Blanco, Childhood maltreatment and the course of bipolar disorders among adults: Epidemiologic evidence of dose-response effects, Journal of Affective Disorders, 2014, 165, 74

    CrossRef

  2. 2
    Lars Vedel Kessing, Hanne Vibe Hansen, Ellen Margrethe Christensen, Henrik Dam, Christian Gluud, Jørn Wetterslev, Do young adults with bipolar disorder benefit from early intervention?, Journal of Affective Disorders, 2014, 152-154, 403

    CrossRef

  3. 3
    V. Rocha-Rego, J. Jogia, A. F. Marquand, J. Mourao-Miranda, A. Simmons, S. Frangou, Examination of the predictive value of structural magnetic resonance scans in bipolar disorder: a pattern classification approach, Psychological Medicine, 2014, 44, 03, 519

    CrossRef

  4. 4
    Ana C. García-Blanco, Pilar Sierra, Lorenzo Livianos, Nosología, epidemiología y etiopatogenia del trastorno bipolar: Últimas aproximaciones, Psiquiatría Biológica, 2014, 21, 3, 89

    CrossRef

  5. 5
    Philippe Conus, Craig Macneil, Patrick D McGorry, Public health significance of bipolar disorder: implications for early intervention and prevention, Bipolar Disorders, 2014, 16, 5
  6. 6
    Kate EA Saunders, Keith Hawton, Clinical assessment and crisis intervention for the suicidal bipolar disorder patient, Bipolar Disorders, 2013, 15, 5
  7. You have free access to this content7
    A. H. Young, A. Hale, Patients with bipolar disorder in a bipolar clinic setting: practical steps, Acta Psychiatrica Scandinavica, 2013, 127,
  8. 8
    Stephanie McMurrich, Louisa G Sylvia, Jamie M Dupuy, Andrew D Peckham, Amy T Peters, Thilo Deckersbach, Roy H Perlis, Course, outcomes, and psychosocial interventions for first-episode mania, Bipolar Disorders, 2012, 14, 8
  9. 9
    Lakshmi N. Yatham, A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder, Journal of Affective Disorders, 2011, 128, S21

    CrossRef

  10. 10
    P.-M. Llorca, Antipsychotiques de seconde génération dans la dépression bipolaire : une nouvelle option thérapeutique ?, L'Encéphale, 2011, 37, S209

    CrossRef

  11. 11
    Elisa Brietzke, Camila L.R. Moreira, Ricardo A. Toniolo, Beny Lafer, Clinical correlates of eating disorder comorbidity in women with bipolar disorder type I, Journal of Affective Disorders, 2011, 130, 1-2, 162

    CrossRef

  12. 12
    Rosario de Arce, Miguel Ángel Jiménez-Arriero, José Luís Rodríguez-Calvin, José María Ruiz-Aguado, Silvia Zaragoza-Domingo, Silvia Cobaleda, Eduard Vieta, Subsyndromal Depressive Symptoms in Bipolar II Disorder: a Community Mental Health Services Cohort Study (SIN-DEPRES), Revista Colombiana de Psiquiatría, 2011, 40, 13S

    CrossRef

  13. 13
    Churn-Shiouh Gau, Ching-Jui Chang, Fang-Ju Tsai, Pei-Fong Chao, Susan Shur-Fen Gau, Association between mood stabilizers and hypothyroidism in patients with bipolar disorders: a nested, matched case-control study, Bipolar Disorders, 2010, 12, 3
  14. 14
    Jay D. Amsterdam, Justine Shults, Efficacy and Mood Conversion Rate of Short-Term Fluoxetine Monotherapy of Bipolar II Major Depressive Episode, Journal of Clinical Psychopharmacology, 2010, 30, 3, 306

    CrossRef

  15. 15
    T. Treuer, M. Tohen, Predicting the course and outcome of bipolar disorder: A review, European Psychiatry, 2010, 25, 6, 328

    CrossRef

  16. 16
    Ph. Conus, Premier épisode thymique : cas particulier de l’intervention dans la phase précoce des troubles bipolaires, L'Encéphale, 2010, 36, S71

    CrossRef

  17. 17
    Philippe Conus, Sue Cotton, Benno G Schimmelmann, Michael Berk, Rothanthi Daglas, Patrick D McGorry, Martin Lambert, Pretreatment and outcome correlates of past sexual and physical trauma in 118 bipolar I disorder patients with a first episode of psychotic mania, Bipolar Disorders, 2010, 12, 3
  18. 18
    Robert K. McNamara, Jayasree J. Nandagopal, Stephen M. Strakowski, Melissa P. DelBello, Preventative Strategies for Early-Onset Bipolar Disorder, CNS Drugs, 2010, 24, 12, 983

    CrossRef

  19. 19
    Colin A Depp, Brent T Mausbach, Philip D Harvey, Christopher R Bowie, Paula S Wolyniec, Mary H Thornquist, James R Luke, John A McGrath, Ann E Pulver, Thomas L Patterson, Social competence and observer-rated social functioning in bipolar disorder, Bipolar Disorders, 2010, 12, 8
  20. 20
    Trine Vik Lagerberg, Sara Larsson, Kjetil Sundet, Charlotte B. Hansen, Tone Hellvin, Ole A. Andreassen, Ingrid Melle, Treatment Delay and Excessive Substance Use in Bipolar Disorder, The Journal of Nervous and Mental Disease, 2010, 198, 9, 628

    CrossRef

  21. 21
    Flávio Kapczinski, Vasco Videira Dias, Marcia Kauer-Sant’Anna, Benicio Noronha Frey, Rodrigo Grassi-Oliveira, Francesc Colom, Michael Berk, Clinical implications of a staging model for bipolar disorders, Expert Review of Neurotherapeutics, 2009, 9, 7, 957

    CrossRef

  22. 22
    Jay D. Amsterdam, Justine Shults, Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?, Journal of Affective Disorders, 2009, 115, 1-2, 234

    CrossRef

  23. 23
    Michael Berk, Gin S. Malhi, Karen Hallam, Clarissa S. Gama, Seetal Dodd, Ana Cristina Andreazza, Benício N. Frey, Flavio Kapczinski, Early intervention in bipolar disorders: Clinical, biochemical and neuroimaging imperatives, Journal of Affective Disorders, 2009, 114, 1-3, 1

    CrossRef

  24. You have free access to this content24
    Yamima Osher, R. H. Belmaker, Omega-3 Fatty Acids in Depression: A Review of Three Studies, CNS Neuroscience & Therapeutics, 2009, 15, 2
  25. 25
    Flávio Kapczinski, Vasco Videira Dias, Márcia Kauer-Sant'Anna, Elisa Brietzke, Gustavo H. Vázquez, Eduard Vieta, Michael Berk, The potential use of biomarkers as an adjunctive tool for staging bipolar disorder, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2009, 33, 8, 1366

    CrossRef

  26. 26
    Rif S. El-Mallakh, S. Nassir Ghaemi, Kemal Sagduyu, Michael E. Thase, Stephen R. Wisniewski, Andrew A. Nierenberg, Hong Wei Zhang, Tamara A. Pardo, Gary Sachs, Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients, Journal of Affective Disorders, 2008, 111, 2-3, 372

    CrossRef

  27. 27
    Erin E Michalak, Greg Murray, Allan H Young, Raymond W Lam, Burden of Bipolar Depression, CNS Drugs, 2008, 22, 5, 389

    CrossRef

  28. 28
    Steven H. Jones, Gerrard Burrell-Hodgson, Cognitive–behavioural treatment of first diagnosis bipolar disorder, Clinical Psychology & Psychotherapy, 2008, 15, 6
  29. 29
    Carmen Andreescu, Benoit H. Mulsant, James E. Emanuel, Complementary and alternative medicine in the treatment of bipolar disorder — A review of the evidence, Journal of Affective Disorders, 2008, 110, 1-2, 16

    CrossRef

  30. 30
    Jennifer E. Wildes, Marsha D. Marcus, Andrea Fagiolini, Prevalence and correlates of eating disorder co-morbidity in patients with bipolar disorder, Psychiatry Research, 2008, 161, 1, 51

    CrossRef

  31. 31
    Lori Altshuler, Susan Bookheimer, Jennifer Townsend, Manuel A Proenza, Fred Sabb, Jim Mintz, Mark S Cohen, Regional brain changes in bipolar I depression: a functional magnetic resonance imaging study, Bipolar Disorders, 2008, 10, 6
  32. 32
    Philippe Conus, Janine Ward, Karen T Hallam, Nellie Lucas, Craig Macneil, Patrick D McGorry, Michael Berk, The proximal prodrome to first episode mania – a new target for early intervention, Bipolar Disorders, 2008, 10, 5
  33. 33
    Michael Berk, Early intervention in bipolar disorders, Acta Neuropsychiatrica, 2007, 19, 1
  34. 34
    Jennifer E. Wildes, Marsha D. Marcus, Andrea Fagiolini, Eating disorders and illness burden in patients with bipolar spectrum disorders, Comprehensive Psychiatry, 2007, 48, 6, 516

    CrossRef

  35. 35
    Edward H. Clayton, Tanya L. Hanstock, Manohar L. Garg, Philip L. Hazell, Long chain omega-3 polyunsaturated fatty acids in the treatment of psychiatric illnesses in children and adolescents, Acta Neuropsychiatrica, 2007, 19, 2
  36. 36
    Janet Wozniak, Joseph Biederman, Eric Mick, James Waxmonsky, Liisa Hantsoo, Catherine Best, Joanne E. Cluette-Brown, Michael Laposata, Omega-3 fatty acid monotherapy for pediatric bipolar disorder: A prospective open-label trial, European Neuropsychopharmacology, 2007, 17, 6-7, 440

    CrossRef

  37. 37
    A. Konstantinidis, W. Hrubos, G. Nirnberger, E. Windhager, M. Lehofer, H. Aschauer, S. Kasper, Quetiapine in combination with citalopram in patients with unipolar psychotic depression, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2007, 31, 1, 242

    CrossRef

  38. 38
    E Vieta, JR Calabrese, JM Goikolea, S Raines, W Macfadden, Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study, Bipolar Disorders, 2007, 9, 4
  39. 39
    Charles L Bowden, Spectrum of effectiveness of valproate in neuropsychiatry, Expert Review of Neurotherapeutics, 2007, 7, 1, 9

    CrossRef

  40. 40
    Jeffrey Yao, Ravinder Reddy, Matthew Muldoon, Sarah Conklin, Fatty Acids in Foods and their Health Implications,Third Edition, 2007,

    CrossRef

  41. 41
    Hilary P. Blumberg, John H. Krystal, Ravi Bansal, Andrés Martin, James Dziura, Kathleen Durkin, Laura Martin, Elizabeth Gerard, Dennis S. Charney, Bradley S. Peterson, Age, Rapid-Cycling, and Pharmacotherapy Effects on Ventral Prefrontal Cortex in Bipolar Disorder: A Cross-Sectional Study, Biological Psychiatry, 2006, 59, 7, 611

    CrossRef

  42. 42
    Susan L McElroy, Renu Kotwal, Rakesh Kaneria, Paul E Keck, Antidepressants and suicidal behavior in bipolar disorder, Bipolar Disorders, 2006, 8, 5p2
  43. 43
    Hani Raoul Khouzam, Fiza Singh, Bipolar disorder: historic perspective, current pharmacologic treatment options and a review of quetiapine, Expert Review of Neurotherapeutics, 2006, 6, 2, 131

    CrossRef

  44. 44
    Krithika Rajagopalan, Nathan L. Kleinman, Richard A. Brook, Harold H. Gardner, Truman J. Brizee, James E. Smeeding, Costs of physical and mental comorbidities among employees: a comparison of those with and without bipolar disorder, Current Medical Research and Opinion, 2006, 22, 3, 443

    CrossRef

  45. 45
    Matthew L MacDonald, Alipi Naydenov, Melissa Chu, David Matzilevich, Christine Konradi, Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder, Bipolar Disorders, 2006, 8, 3
  46. 46
    Robert M. Post, Lori L. Altshuler, Mark A. Frye, Trisha Suppes, Susan McElroy, Paul E. Keck, Gabriele S. Leverich, Ralph Kupka, Willem A. Nolen, Heinz Grunze, New findings from the bipolar collaborative network: Clinical implications for therapeutics, Current Psychiatry Reports, 2006, 8, 6, 489

    CrossRef

  47. 47
    Michael Strober, Boris Birmaher, Neal Ryan, David Axelson, Sylvia Valeri, Henrietta Leonard, Satish Iyengar, Mary Kay Gill, Jeffrey Hunt, Martin Keller, Pediatric bipolar disease: current and future perspectives for study of its long-term course and treatment, Bipolar Disorders, 2006, 8, 4
  48. 48
    Philippe Conus, Michael Berk, Patrick D. McGorry, Pharmacological treatment in the early phase of bipolar disorders: what stage are we at?, Australian and New Zealand Journal of Psychiatry, 2006, 40, 3, 199

    CrossRef

  49. 49
    Philippe Conus, Michael Berk, Patrick D. McGorry, Pharmacological treatment in the early phase of bipolar disorders: what stage are we at?, Australian and New Zealand Journal of Psychiatry, 2006, 40, 3
  50. 50
    Christoph Born, Florian Seemüller, Heinz Grunze, Quetiapine: an approach for the treatment of bipolar disorders, Future Neurology, 2006, 1, 2, 131

    CrossRef

  51. 51
    M Gitlin, Treatment-resistant bipolar disorder, Molecular Psychiatry, 2006, 11, 3, 227

    CrossRef

  52. 52
    Paul E Keck, Bipolar depression: a new role for atypical antipsychotics?, Bipolar Disorders, 2005, 7,
  53. 53
    Michael E. Thase, Bipolar Depression: Issues in Diagnosis and Treatment, Harvard Review of Psychiatry, 2005, 13, 5, 257

    CrossRef

  54. 54
    Jay D. Amsterdam, Justine Shults, Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression—lack of manic induction, Journal of Affective Disorders, 2005, 87, 1, 121

    CrossRef

  55. 55
    George R. Brown, Linda McBride, Mark S. Bauer, William O. Williford, Impact of childhood abuse on the course of bipolar disorder: A replication study in U.S. veterans, Journal of Affective Disorders, 2005, 89, 1-3, 57

    CrossRef

  56. 56
    Eduard Vieta, Mood stabilization in the treatment of bipolar disorder: focus on quetiapine, Human Psychopharmacology: Clinical and Experimental, 2005, 20, 4
  57. 57
    K Ranga Rama Krishnan, Psychiatric and Medical Comorbidities of Bipolar Disorder, Psychosomatic Medicine, 2005, 67, 1, 1

    CrossRef

  58. 58
    Toni M Dando, Gillian M Keating, Quetiapine, Drugs, 2005, 65, 17, 2533

    CrossRef

  59. 59
    I Schweitzer, K Maguire, CH Ng, Should bipolar disorder be viewed as manic disorder? Implications for bipolar depression, Bipolar Disorders, 2005, 7, 5
  60. 60
    Robert M Post, Joseph R Calabrese, Bipolar depression: the role of atypical antipsychotics, Expert Review of Neurotherapeutics, 2004, 4, 6s2, S27

    CrossRef

  61. 61
    Colin A Depp, Dilip V Jeste, Bipolar disorder in older adults: a critical review, Bipolar Disorders, 2004, 6, 5
  62. 62
    Robert K. McNamara, Robert H. Lenox, The myristoylated alanine-rich C kinase substrate: a lithium-regulated protein linking cellular signaling and cytoskeletal plasticity, Clinical Neuroscience Research, 2004, 4, 3-4, 155

    CrossRef

  63. 63
    Alan C. Swann, Practical Pharmacological Maintenance Treatment of Bipolar Disorder,